Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q4 2025 Earnings Call Transcript
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q4 2025 Earnings Call Transcript February 27, 2026Treace Medical Concepts, Inc. beats earnings expectations.
Treace Medical Concepts Inc. (TMCI)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bronte Capital John Hempton | 15,577 | $61,996 | 0.01% | |
| 2. | NVerses Capital Jb Kim | 10,696 | $42,570 | 0.07% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.04 | 9,891 | $39,982.39 | 7,348,439 | 2026-06-11 | Filing | |
| $4.02 | 14,715 | $59,213.16 | 7,338,548 | 2026-06-10 | Filing | |
| $4.04 | 22,887 | $92,541.30 | 7,376,150 | 2026-06-11 | Filing | |
| $4.02 | 29,430 | $118,426.32 | 7,353,263 | 2026-06-10 | Filing | |
| $3.56 | 50,000 | $177,915.00 | 7,323,833 | 2026-06-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.97 | 50,000 | $398,460.00 | 364,081 | 2025-03-17 | Filing | |
| $24.02 | 1,700 | $40,828.39 | 1,036,441 | 2022-11-15 | Filing | |
| $21.97 | 200 | $4,394.00 | 1,038,141 | 2022-11-15 | Filing | |
| $21.18 | 1,600 | $33,890.08 | 1,038,341 | 2022-11-15 | Filing | |
| $20.12 | 46,500 | $935,580.00 | 1,039,941 | 2022-11-15 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,029,543 | $12,057,581 | 2.32% | |
| 2. | 1,534,034 | $6,105,455 | 3.88% | |
| 3. | 1,380,021 | $5,492,483 | 0% | |
| 4. | 234,271 | $932,399 | 0% | |
| 5. | 103,758 | $412,957 | 0% |
News See All
Stifel Revises Treace Medical Concepts, Inc. (TMCI) Price Target in Sector-Wide Update
Treace Medical Concepts is one of the high-growth micro-cap stocks to buy. On January 7, Stifel lowered its price target on Treace Medical Concepts, Inc.
11 High Growth Micro-cap Stocks to Buy
Investing in stocks of companies with market values under $300 million, otherwise known as micro-cap stocks, offers a unique opportunity to get in early on fast-growing businesses.
10 Best Biotech Penny Stocks to Buy According to Analysts
On December 24, Jared Holz of Mizuho joined 'Power Lunch' on CNBC to talk about how to play biotech moving into 2026.
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q3 2025 Earnings Call Transcript
Trip Taylor: Good afternoon, everyone, and welcome to our third quarter 2025 earnings conference call.
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q2 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Treace Medical Concepts Second Quarter 2025 Earnings Conference Call.
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q1 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Treace Medical Concepts, Inc. first quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode.
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q4 2024 Earnings Call Transcript
Operator: Welcome to the Treace Medical Concepts Fourth Quarter 2024 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
Why Treace Medical Concepts (TMCI) Is Rallying Today
Treace provides technology that facilitates Lapiplasty bunion surgery and related midfoot deformities.
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q3 2024 Earnings Call Transcript
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q3 2024 Earnings Call Transcript November 5, 2024Treace Medical Concepts, Inc. beats earnings expectations.
Hedge Fund Resource Center